HRT Financial’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,046
Closed -$269K 2594
2024
Q4
$269K Sell
14,046
-2,505
-15% -$47.3K ﹤0.01% 1776
2024
Q3
$306K Buy
+16,551
New +$307K ﹤0.01% 1801
2024
Q2
Sell
-13,216
Closed -$228K 2302
2024
Q1
$228K Buy
+13,216
New +$222K ﹤0.01% 1703
2023
Q2
Sell
-21,114
Closed -$287K 2536
2023
Q1
$287K Buy
21,114
+7,572
+56% +$110K ﹤0.01% 1736
2022
Q4
$173K Buy
+13,542
New +$184K ﹤0.01% 1966
2022
Q3
Sell
-29,646
Closed -$459K 2854
2022
Q2
$459K Buy
29,646
+8,610
+41% +$148K 0.01% 1721
2022
Q1
$374K Buy
+21,036
New +$376K ﹤0.01% 2080

Other funds holding CCAP

HRT Financial's CCAP Position: Q1 2025 in Review

HRT Financial sold out of Crescent Capital BDC (CCAP) in Q1 2025, closing a stake of 14,046 shares — an estimated $269K sold.

HRT Financial first reported a position in CCAP in Q1 2022 and held it in 7 quarters. The position peaked at $459K in Q2 2022. 88 funds tracked by Wall St. Rank hold CCAP as of Q1 2025.

  • HRT Financial reported no remaining Crescent Capital BDC position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 14,046 Crescent Capital BDC shares in Q1 2025, an estimated $269K.
  • HRT Financial first reported a position in Crescent Capital BDC in Q1 2022 and held it in 7 quarters.
  • HRT Financial's Crescent Capital BDC position peaked at $459K in Q2 2022.
  • 88 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.